NCT05019209View on ClinicalTrials.gov

Skin Responses and T Cell Immunology After House Dust Mite Exposure in Sensitized Atopic Dermatitis Patients

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

September 10, 2021

Primary Completion Date

February 14, 2022

Study Completion Date

February 14, 2022

Conditions
Atopic DermatitisHouse Dust Mite Allergy
Interventions
DRUG

House Dust Mite Allergen

D. pteronyssinus lyophilisate dissolved in 5% sodium chloride solution, spray dried

OTHER

Allergen-free air

No allergen added to room ventilation of allergen challenge chamber

Trial Locations (2)

30625

Fraunhofer Institute for Toxicology and Experimental Medicine, Hanover

Hannover Medical School, Department of Dermatology and Allergy, Hanover

All Listed Sponsors
collaborator

Hannover Medical School

OTHER

lead

Fraunhofer-Institute of Toxicology and Experimental Medicine

OTHER

NCT05019209 - Skin Responses and T Cell Immunology After House Dust Mite Exposure in Sensitized Atopic Dermatitis Patients | Biotech Hunter | Biotech Hunter